Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for example, inflammation, cancer or autoimmune disease.
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
The present invention relates to hydroximoyl-tetrazole derivatives of formula (I) wherein T represent a tetrazolyl substituent, A represents a carbo- or heterocycle, L
1
and L
2
represent various linking groups and Q represents a 6-membered heterocycle, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
作者:Aleksei B. Sheremetev、Andrei S. Kozeev、Nadezhda V. Palysaeva、Kyrill Yu. Suponitsky
DOI:10.1039/d3nj03371f
日期:——
An efficient, one-pot protocol for the synthesis of aminofurazans from readily available and inexpensive bromomethyl ketones has been developed. Alkyl, aryl and heteroaryl aminofurazans have been synthesized and characterized by multinuclear NMR and single crystal X-ray crystallography.